DC Circ. Rejects Esai's Petition Over Seizure Med Delay
The D.C. Circuit on Tuesday shot down a bid from a U.S. unit of Japan's Eisai Co. Ltd. to force the U.S. Drug Enforcement Administration to speed up the process for...To view the full article, register now.
Already a subscriber? Click here to view full article